Cite
Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial.
MLA
Meya, David B., et al. “Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/ΜL: A Stepped-Wedge, Cluster-Randomized Trial.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 80, no. 2, Feb. 2019, pp. 182–89. EBSCOhost, https://doi.org/10.1097/QAI.0000000000001894.
APA
Meya, D. B., Kiragga, A. N., Nalintya, E., Morawski, B. M., Rajasingham, R., Park, B. J., Mubiru, A., Kaplan, J. E., Manabe, Y. C., & Boulware, D. R. (2019). Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial. Journal of Acquired Immune Deficiency Syndromes (1999), 80(2), 182–189. https://doi.org/10.1097/QAI.0000000000001894
Chicago
Meya, David B, Agnes N Kiragga, Elizabeth Nalintya, Bozena M Morawski, Radha Rajasingham, Benjamin J Park, Anthony Mubiru, Jonathan E Kaplan, Yukari C Manabe, and David R Boulware. 2019. “Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/ΜL: A Stepped-Wedge, Cluster-Randomized Trial.” Journal of Acquired Immune Deficiency Syndromes (1999) 80 (2): 182–89. doi:10.1097/QAI.0000000000001894.